(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ALCHEMEDICINE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ALCHEMEDICINE

ST13

US500000079275647

Class

5, 42

Filing

79275647

Registration

6182153

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

10/28/2025

Trademark type

Word

Nice classes

5, 42

Filing date

11/08/2019

Registration date

10/27/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/27/2020

Last transaction

10/28/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

JP

Examiner

EISNACH,MICHAEL PATRICK

Law office

L40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Alchemedicine Inc.

Representatives

Kathryn Swint Pirkey Barber PLLC

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations and substancespharmaceutical preparations for the treatment of cancermusculo-skeletal disordersimmune system related diseases and disordersgastro-intestinal diseasescardiovascular disorderscentral nervous system diseaseshypertensionblood disorderspaininflammationmetabolic disordersgenitourinary disordersoncological disordershepatological disorderskidney diseasesneurological disordersinflammatory disordersarthritiscognitive disorders; pharmaceutical preparations for use in urologychemotherapythe field of oncology; pharmaceutical preparations acting on the central nervous system; anti-inflammatories; veterinary preparationsnamely veterinary pharmaceutical preparations for the treatment of cancernervous system disorderscardiovascular diseasesmusculoskeletal disordersgastrointestinal disordersimmune system diseasesgenito-urinary system diseasesendocrine and metabolic system diseasesinflammation; veterinary preparationspain relief medication; chemical preparations for pharmaceutical purposes for the treatment of cancermusculo-skeletal disordersimmune system related diseases and disordersgastro-intestinal diseasescardiovascular disorderscentral nervous system diseaseshypertensionblood disorderspaininflammationmetabolic disordersgenitourinary disordersoncological disordershepatological disorderskidney diseasesneurological disordersinflammatory disordersarthritiscognitive disorders; chemical reagents for medical or veterinary purposes; diagnostic reagents for medical or veterinary purposes; sanitary preparations for medical purposes

Class 42

Testinginspectionresearch or development services in the fields of pharmaceutical preparationsmedicinescosmetics and foodstuffs; advisoryconsultancy and information services relating to testinginspectionresearch or development of pharmaceutical preparationsmedicinescosmetics and foodstuffs; testinginspection or research of chemical compounds and pharmaceutical compoundsadvisoryconsultancy and information services relating thereto; chemical research and analysis servicesadvisoryconsultancy and information services relating thereto

Publications

History of USPTO decisions and trademark events.

28 publications found

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

10/27/2025

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

07/23/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

03/07/2021

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/11/2021

FIMP

FINAL DISPOSITION PROCESSED

02/11/2021

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/27/2021

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

12/18/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

10/27/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/11/2020

PUBO

PUBLISHED FOR OPPOSITION

08/11/2020

GPNX

NOTIFICATION PROCESSED BY IB

08/07/2020

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

07/22/2020

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

07/22/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/22/2020

ALIE

ASSIGNED TO LIE

07/07/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/02/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/01/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/30/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/30/2020

RFNT

REFUSAL PROCESSED BY IB

04/03/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/13/2020

RFRR

REFUSAL PROCESSED BY MPU

03/12/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

02/20/2020

CNRT

NON-FINAL ACTION WRITTEN

02/19/2020

DOCK

ASSIGNED TO EXAMINER

02/12/2020

MAFR

APPLICATION FILING RECEIPT MAILED

01/14/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/08/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

01/02/2020

Continuous trademark protection

Get notified about every new filing that threatens ALCHEMEDICINE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.